CANCER PROGRESSION: IMMUNOHISTOCHEMICAL STUDY OF SURVIVIN AND XIAP IN NORMAL AND PATHOLOGICAL (BENIGN HYPERPLASTIC AND CANCER) HUMAN PROSTATE

被引：0
|
作者：
Fraile, B. [1 ]
Chaves, C. [1 ]
Rodriguez-Berruguete, Gonzalo [1 ]
Nunez, C. [1 ]
Martinez-Onsurbe, P. [2 ]
Olmedilla, G. [2 ]
Bethecourt, F. [3 ]
Cansino, R. [3 ]
Paniagua, R. [3 ]
Royuela, M. [1 ]
机构：
[1] Univ Alcala de Henares, Dept Cell Biol & Genet, Alcala De Henares 99775, Spain
[2] Principe Asturias Hosp, Dept Pathol, Alcala De Henares, Spain
[3] Hosp La Paz, Dept Urol, Madrid, Spain
来源：
ANTICANCER RESEARCH | 2008年 / 28卷 / 5C期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
206
引用
收藏
页码：3283 / 3284
页数：2
相关论文
共 50 条
  • [1] Role of IAPs in prostate cancer progression: immunohistochemical study in normal and pathological (benign hyperplastic, prostatic intraepithelial neoplasia and cancer) human prostate
    Gonzalo Rodríguez-Berriguete
    Benito Fraile
    Fermín R de Bethencourt
    Angela Prieto-Folgado
    Nahikari Bartolome
    Claudia Nuñez
    Bruna Prati
    Pilar Martínez-Onsurbe
    Gabriel Olmedilla
    Ricardo Paniagua
    Mar Royuela
    BMC Cancer, 10
  • [2] Role of IAPs in prostate cancer progression: immunohistochemical study in normal and pathological (benign hyperplastic, prostatic intraepithelial neoplasia and cancer) human prostate
    Rodriguez-Berriguete, Gonzalo
    Fraile, Benito
    de Bethencourt, Fermin R.
    Prieto-Folgado, Angela
    Bartolome, Nahikari
    Nunez, Claudia
    Prati, Bruna
    Martinez-Onsurbe, Pilar
    Olmedilla, Gabriel
    Paniagua, Ricardo
    Royuela, Mar
    BMC CANCER, 2010, 10
  • [3] IMMUNOHISTOCHEMICAL STUDY OF METALLOTHIONEIN IN NORMAL AND BENIGN PROSTATIC HYPERPLASIA OF HUMAN PROSTATE
    SUZUKI, T
    UMEYAMA, T
    OHMA, C
    YAMANAKA, H
    SUZUKI, K
    NAKAJIMA, K
    KIMURA, M
    PROSTATE, 1991, 19 (01): : 35 - 42
  • [4] NO PROLACTIN RECEPTORS IN NORMAL, BENIGN HYPERPLASTIC AND MALIGNANT HUMAN-PROSTATE
    BLANKENSTEIN, MA
    BOLTDEVRIES, J
    SCHROEDER, FH
    PROSTATE, 1983, 4 (06): : 653 - 653
  • [5] PrLZ is expressed in normal prostate development and in human prostate cancer progression
    Wang, Ruoxiang
    Xu, Jianchun
    Mabjeesh, Nicola
    Zhu, Guodong
    Zhou, Jianguang
    Amin, Mahul
    He, Dalin
    Marshall, Fray F.
    Zhau, Haiyen E.
    Chung, Leland W. K.
    CLINICAL CANCER RESEARCH, 2007, 13 (20) : 6040 - 6048
  • [6] Presence of 5α-reductase isozymes and aromatase in human prostate cancer cells and in benign prostate hyperplastic tissue
    Negri-Cesi, P
    Poletti, A
    Colciago, A
    Magni, P
    Martini, P
    Motta, M
    PROSTATE, 1998, 34 (04): : 283 - 291
  • [7] IMMUNOHISTOCHEMICAL STUDY OF ANDROGEN RECEPTOR IN BENIGN HYPERPLASTIC AND CANCEROUS HUMAN PROSTATES
    MASAI, M
    SUMIYA, H
    AKIMOTO, S
    YATANI, R
    CHANG, CS
    LIAO, SS
    SHIMAZAKI, J
    PROSTATE, 1990, 17 (04): : 293 - 300
  • [8] Pathological aspects of prostate cancer and benign nodular hyperplasia
    Wernert, N
    Bieroff, E
    Hugel, A
    ANTICANCER RESEARCH, 1997, 17 (4B) : 2907 - 2910
  • [9] Influence of Lycopene on Cell Viability, Cell Cycle, and Apoptosis of Human Prostate Cancer and Benign Hyperplastic Cells
    Pereira Soares, Nathalia da Costa
    Teodoro, Anderson Junger
    Oliveira, Felipe Leite
    do Nascimento Santos, Carlos Antonio
    Takiya, Christina Maeda
    Saback Junior, Oswaldo
    Bianco, Mario
    Palumbo Junior, Antonio
    Nasciutti, Luiz Eurico
    Ferreira, Luciana Bueno
    Pereira Gimba, Etel Rodrigues
    Borojevic, Radovan
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2013, 65 (07): : 1076 - 1085
  • [10] IMMUNOHISTOCHEMICAL DETERMINATION OF AGE-RELATED PROLIFERATION RATES IN NORMAL AND BENIGN HYPERPLASTIC HUMAN PROSTATES
    CLAUS, S
    WRENGER, M
    SENGE, T
    SCHULZE, H
    UROLOGICAL RESEARCH, 1993, 21 (05): : 305 - 308
12345